about
Total ankle replacement versus arthrodesis (TARVA): protocol for a multicentre randomised controlled trial.ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.Albumin Prevents Infections in Patients with Chronic Liver Failure in a Single-arm Feasibility Trial.Albumin Counteracts Immune-suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease.Erratum to: ‘Novel patient engagement and recruitment strategies for an RCT of two NHS treatments for ankle osteoarthritis - total ankle replacement versus arthrodesis - the TARVA trial’.Novel patient engagement and recruitment strategies for an RCY of two NHS treatments for ankle osteoarthritis - total ankle replacement versus arthrodesis - the TARVA trial.The analysis of very small samples of repeated measurements II: a modified Box correction.Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trial.The analysis of very small samples of repeated measurements I: an adjusted sandwich estimator.Ophthalmic statistics note 9: parametric versus non-parametric methods for data analysis.Post hoc analysis of the Exenatide-PD trial-Factors that predict responseAssessing the respective contributions of dietary flavanol monomers and procyanidins in mediating cardiovascular effects in humans: randomized, controlled, double-masked intervention trialATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trialUtility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD TrialWhat Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc AnalysisBlue light exposure decreases systolic blood pressure, arterial stiffness, and improves endothelial function in humansImmune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality
P50
Q34539644-9F88BA0A-6689-49D1-A88E-A032B6C208CBQ36527179-FF182A8C-3AA7-4CF1-AE5F-29CA70D1537AQ40045308-A66ADE4B-8181-409E-B5D4-9FF3EE9725CFQ40072046-1622FC56-8452-49EF-9624-EDB75AD2947CQ45775686-C8EAFE5B-F66B-4C77-B929-2E23046D51AFQ45918526-74AB3C21-7EF2-4CE7-BCFC-5CE634CB6B08Q46397905-4B0CA8A0-ECC8-4699-8DE6-89C30913B82DQ47642462-F77BB455-6259-402E-8833-BC5D24D89FCDQ51661448-6C086876-B796-49C8-B2A2-0971ED45206DQ53798085-AC86701B-A7F4-4BCB-9D3D-0F5EC9242423Q57171131-FB42C52D-4DB0-4B15-AB11-12E0FF8B3DB3Q57789451-6A086D8D-3A77-48CC-B38C-031937F9E34EQ57806275-9E40DB55-993E-4824-9D3D-7C36487C4AB9Q64785443-94F88E89-1978-4894-8B50-58D137B0EF1BQ88907043-3B1CADD9-51C4-4B25-82D4-2692CAD5B4BCQ91344072-C8BD5A7A-3B8C-4F58-A066-3D3D93B9EDEAQ92846715-ADCA94EA-0093-426B-BE35-3B6696B01392
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Simon S Skene
@ast
Simon S Skene
@en
Simon S Skene
@es
Simon S Skene
@nl
Simon S Skene
@sl
type
label
Simon S Skene
@ast
Simon S Skene
@en
Simon S Skene
@es
Simon S Skene
@nl
Simon S Skene
@sl
prefLabel
Simon S Skene
@ast
Simon S Skene
@en
Simon S Skene
@es
Simon S Skene
@nl
Simon S Skene
@sl
P106
P21
P31
P496
0000-0002-7828-3122